Literature DB >> 17456762

Luteogenic hormones act through a vascular endothelial growth factor-dependent mechanism to up-regulate alpha 5 beta 1 and alpha v beta 3 integrins, promoting the migration and survival of human luteinized granulosa cells.

Alexandra Rolaki1, George Coukos, Dimitris Loutradis, Horace M DeLisser, Christos Coutifaris, Antonis Makrigiannakis.   

Abstract

The formation of the corpus luteum (CL) is critical for the establishment of a successful pregnancy. After ovulation, the CL develops from the remnants of the ovulated ovarian follicle. This process, which involves varying cell-matrix interactions, is poorly characterized. To understand the role and potential regulation of cell-matrix interactions in the formation of the CL, we investigated the expression and activity of the matrix protein fibronectin (FN) and several of its integrin receptors on luteinized granulosa cells (GCs). In situ, FN and several FN-binding integrins were detected around luteinizing GCs during the early luteal phase, although expression declined in the late luteal phase. In vitro, GCs released FN, and stimulation of these cells with human chorionic gonadotropin increased the surface expression of FN, alpha(5)beta(1), and alpha(v)beta(3). Up-regulation of these proteins on GCs was reproduced by stimulation with vascular endothelial growth factor (VEGF) and was inhibited by anti-VEGF antibody. Lastly, expression of alpha(5)beta(1) and alpha(v)beta(3) mediated adhesion to FN, facilitated migration, and prevented apoptosis. These data suggest that in vivo luteogenic hormones, in part through a VEGF-dependent mechanism, stimulate selected integrin-matrix adhesive interactions that promote the motility and survival of GCs and thus contribute to the formation and preservation of the CL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456762      PMCID: PMC1854951          DOI: 10.2353/ajpath.2007.060926

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

Review 1.  Follicular atresia and luteolysis. Evidence of a role for N-cadherin.

Authors:  A Makrigiannakis; G Coukos; O Blaschuk; C Coutifaris
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  Expression of Bcl-2 and Bax in the human corpus luteum during the menstrual cycle and in early pregnancy: regulation by human chorionic gonadotropin.

Authors:  N Sugino; T Suzuki; S Kashida; A Karube; S Takiguchi; H Kato
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

Review 3.  Get a ligand, get a life: integrins, signaling and cell survival.

Authors:  Dwayne G Stupack; David A Cheresh
Journal:  J Cell Sci       Date:  2002-10-01       Impact factor: 5.285

4.  Regulated expression and potential roles of p53 and Wilms' tumor suppressor gene (WT1) during follicular development in the human ovary.

Authors:  A Makrigiannakis; K Amin; G Coukos; J L Tilly; C Coutifaris
Journal:  J Clin Endocrinol Metab       Date:  2000-01       Impact factor: 5.958

Review 5.  Regulation and action of angiogenic factors in the primate ovary.

Authors:  R L Stouffer; J C Martínez-Chequer; T A Molskness; F Xu; T M Hazzard
Journal:  Arch Med Res       Date:  2001 Nov-Dec       Impact factor: 2.235

6.  Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.

Authors:  T Endo; Y Kitajima; A Nishikawa; K Manase; M Shibuya; R Kudo
Journal:  Fertil Steril       Date:  2001-10       Impact factor: 7.329

Review 7.  Anchorage dependence, integrins, and apoptosis.

Authors:  E Ruoslahti; J C Reed
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

8.  Progesterone is an autocrine/paracrine regulator of human granulosa cell survival in vitro.

Authors:  A Makrigiannakis; G Coukos; M Christofidou-Solomidou; S Montas; C Coutifaris
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

9.  Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor.

Authors:  H M Fraser; S E Dickson; S F Lunn; C Wulff; K D Morris; V A Carroll; R Bicknell
Journal:  Endocrinology       Date:  2000-03       Impact factor: 4.736

10.  Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2.

Authors:  Christine Wulff; Helen Wilson; Stanley J Wiegand; John S Rudge; Hamish M Fraser
Journal:  Endocrinology       Date:  2002-07       Impact factor: 4.736

View more
  5 in total

1.  Effect of ICSI on gene expression and development of mouse preimplantation embryos.

Authors:  G Giritharan; M W Li; F Di Sebastiano; F De Sebastiano; F J Esteban; J A Horcajadas; K C K Lloyd; A Donjacour; E Maltepe; P F Rinaudo
Journal:  Hum Reprod       Date:  2010-10-01       Impact factor: 6.918

2.  RGD-modified dextran hydrogel promotes follicle growth in three-dimensional ovarian tissue culture in mice.

Authors:  Cassandra Matsushige; Xiaojie Xu; Marissa Miyagi; Yi Y Zuo; Yukiko Yamazaki
Journal:  Theriogenology       Date:  2022-02-17       Impact factor: 2.740

3.  The Upregulation of HAS2-AS1 Relates to the Granulosa Cell Dysfunction by Repressing TGF-β Signaling and Upregulating HAS2.

Authors:  Yungai Xiang; Guo Yu; Yuxia Song; Yan Li; Lanlan Cheng; Pengfen Li; Le Zhang; Meng Wang; Li Tan
Journal:  Mol Cell Biol       Date:  2022-08-08       Impact factor: 5.069

4.  The expression of receptivity markers in the fallopian tube epithelium.

Authors:  A Makrigiannakis; M Karamouti; G Petsas; N Makris; G Nikas; A Antsaklis
Journal:  Histochem Cell Biol       Date:  2009-04-23       Impact factor: 4.304

Review 5.  Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.

Authors:  Samar Masoumi Moghaddam; Afshin Amini; David L Morris; Mohammad H Pourgholami
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.